Rothschild & CO Asset Management Us Inc. Ultragenyx Pharmaceutical Inc. Transaction History

Rothschild & CO Asset Management Us Inc.

$6.56 Billion
Q4 2022

A detailed history of Rothschild & CO Asset Management Us Inc. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Rothschild & CO Asset Management Us Inc. holds 139,517 shares of RARE stock, worth $6.33 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

139,517

Previous 120,667 15.62%

Holding current value

$6.33 Million

Previous $5 Million 29.34%

% of portfolio

0.1%

Previous 0.09%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$33.72 - $46.33 $635,622 - $873,320	18,850 Added 15.62%	139,517 $6.46 Million
Q3 2022 Nov 07, 2022	BUY	$39.96 - $66.14 $2.86 Million - $4.73 Million	71,494 Added 145.39%	120,667 $5 Million
Q2 2022 Aug 09, 2022	BUY	$45.8 - $85.4 $240,678 - $448,777	5,255 Added 11.97%	49,173 $2.93 Million
Q1 2022 May 13, 2022	BUY	$62.2 - $84.4 $2.73 Million - $3.71 Million	43,918 New	43,918 $3.19 Million
Q3 2020 Nov 09, 2020	SELL	$72.98 - $90.0 $9.17 Million - $11.3 Million	-125,683 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$46.91 - $78.22 $759,332 - $1.27 Million	-16,187 Reduced 11.41%	125,683 $9.83 Million
Q1 2020 May 14, 2020	SELL	$33.8 - $62.9 $585,179 - $1.09 Million	-17,313 Reduced 10.88%	141,870 $6.3 Million
Q4 2019 Feb 12, 2020	BUY	$36.08 - $45.83 $1.86 Million - $2.36 Million	51,593 Added 47.95%	159,183 $6.8 Million
Q3 2019 Nov 08, 2019	BUY	$42.5 - $63.11 $98,387 - $146,099	2,315 Added 2.2%	107,590 $4.6 Million
Q2 2019 Jul 25, 2019	BUY	$54.93 - $74.36 $2.73 Million - $3.7 Million	49,735 Added 89.55%	105,275 $6.69 Million
Q1 2019 May 08, 2019	BUY	$39.87 - $69.36 $1.07 Million - $1.87 Million	26,899 Added 93.92%	55,540 $3.85 Million
Q4 2018 Feb 05, 2019	SELL	$38.89 - $77.3 $10,344 - $20,561	-266 Reduced 0.92%	28,641 $1.25 Million
Q3 2018 Nov 13, 2018	SELL	$71.81 - $90.15 $25,851 - $32,454	-360 Reduced 1.23%	28,907 $2.21 Million
Q2 2018 Aug 07, 2018	BUY	$48.54 - $85.31 $291,142 - $511,689	5,998 Added 25.78%	29,267 $2.25 Million
Q1 2018 May 08, 2018	SELL	$44.33 - $58.52 $84,537 - $111,597	-1,907 Reduced 7.57%	23,269 $1.19 Million
Q4 2017 Feb 12, 2018	SELL	$43.54 - $57.32 $81,985 - $107,933	-1,883 Reduced 6.96%	25,176 $1.17 Million
Q3 2017 Nov 08, 2017	BUY	$49.79 - $66.32 $1.35 Million - $1.79 Million	27,059	27,059 $1.44 Million

Others Institutions Holding RARE

# of Institutions

326

Shares Held

85.7M

Call Options Held

520K

Put Options Held

406K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.18B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild & CO Asset Management Us Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rothschild & CO Asset Management Us Inc. with notifications on news.

Account

Rothschild & CO Asset Management Us Inc. Ultragenyx Pharmaceutical Inc. Transaction History